The overall pooled sensitivity and specificity were 0.58 (95% CI = 0.51–0.66) and 0.90 (95% CI = 0.82–0.95), respectively, which suggested that DCLK1 had a relatively considerable accuracy in detecting malignant tumors. The gene discussed is DCLK1; the disease is cancer.